Recent 13F filings as of September 2025 show that 150 institutional investors hold a position in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Nextech Invest, Ltd. | 30 Sep, 2025 | 7,162,637 | 0 | 0.00% | $85,951,644.00 |
| EcoR1 Capital, LLC | 30 Sep, 2025 | 6,728,116 | 5,110,048 | 315.81% | $80,737,392.00 |
| VR Adviser, LLC | 30 Sep, 2025 | 6,596,885 | 0 | 0.00% | $79,162,620.00 |
| VIKING GLOBAL INVESTORS LP | 30 Sep, 2025 | 6,572,700 | 0 | 0.00% | $78,872,400.00 |
| PFIZER INC | 30 Sep, 2025 | 5,376,344 | 0 | 0.00% | $64,516,128.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 5,268,522 | 1,190,537 | 29.19% | $63,222,264.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 4,650,138 | 1,525,445 | 48.82% | $55,801,656.00 |
| SR ONE CAPITAL MANAGEMENT, LP | 30 Sep, 2025 | 4,514,929 | 0 | 0.00% | $54,179,148.00 |
| ALKEON CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 4,504,096 | 0 | 0.00% | $54,049,152.00 |
| NEA Management Company, LLC | 30 Sep, 2025 | 4,118,621 | 0 | 0.00% | $49,423,452.00 |
| ORBIMED ADVISORS LLC | 30 Sep, 2025 | 3,641,756 | 2,742,475 | 304.96% | $43,701,072.00 |
| Column Group LLC | 30 Sep, 2025 | 3,540,777 | 0 | 0.00% | $42,489,324.00 |
| Vivo Capital, LLC | 30 Sep, 2025 | 3,126,604 | 0 | 0.00% | $37,519,248.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 30 Sep, 2025 | 2,871,327 | 108,412 | 3.92% | $34,457.00 |
| Point72 Asset Management, L.P. | 30 Sep, 2025 | 2,619,914 | -230,727 | -8.09% | $31,438,968.00 |
| FMR LLC | 30 Sep, 2025 | 2,528,048 | 57,991 | 2.35% | $30,336,576.00 |
| STATE STREET CORP | 30 Sep, 2025 | 2,403,939 | 771,823 | 47.29% | $28,847,268.00 |
| First Turn Management, LLC | 30 Sep, 2025 | 2,159,474 | 149,551 | 7.44% | $25,913,688.00 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 1,948,808 | 147,979 | 8.22% | $23,385,696.00 |
| MPM BioImpact LLC | 30 Sep, 2025 | 1,729,378 | 0 | 0.00% | $20,752,536.00 |